By exploiting albumin pathways, nanoparticles could transport across the endothelium of blood vessels via Gp60 and caveolae-mediated transcytosis process and also by association with the albumin-binding protein SPARC [19] which may play an important role in the increased tumor accumulation of albumin-bound drugs. This evidence concerns the gene SPARC and neoplasm.